The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a ...
The International Mathematical Olympiad (IMO) is a prestigious competition featuring talented high school students from around the world, in which competitors solve complicated mathematical problems.